Can sarcoidosis patients safely stop their biologic drug? major trial aims to find out
NCT ID NCT05689879
Summary
This study aims to find out if patients with severe sarcoidosis who are in remission can safely stop their infliximab treatment. It will compare two strategies: stopping the drug versus continuing it, in 90 adults who have been stable for at least 6 months. The main goal is to see which approach better prevents the disease from coming back over one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOIDOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital de la Pitié-Salpêtrière
RECRUITINGParis, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.